Guy's and StThomas NHS Trust, Guy's Hospital, St Thomas Street, London, UK.
Cancer Imaging. 2004 Feb 14;4 Spec No A(Spec No A):S22-4. doi: 10.1102/1470-7330.2004.0013.
Imaging plays a vital role in the management of non-small cell lung cancer including diagnosis, staging and follow-up. CT and magnetic resonance imaging (MRI) are used in staging and provide anatomical information but have well known limitations in differentiating reactive from malignant nodes, and fibrosis from active disease and in defining the extent of invasion. MRI with its superior soft tissue contrast provides optimal information on brachial plexus and central nervous system involvement. Functional imaging using 2-18 fluoro-deoxyglucose positron emission tomography is increasingly being used to provide unique information and when combined with anatomic imaging will provide better staging information for both local disease and the extent of metastases.
影像学在非小细胞肺癌的管理中起着至关重要的作用，包括诊断、分期和随访。CT 和磁共振成像（MRI）用于分期，提供解剖信息，但在区分反应性和恶性淋巴结、纤维化和活动性疾病以及确定侵袭范围方面存在明显的局限性。MRI 具有优越的软组织对比度，可提供最佳的臂丛神经和中枢神经系统受累信息。使用 2-18 氟脱氧葡萄糖正电子发射断层扫描进行功能成像，越来越多地用于提供独特的信息，并且当与解剖成像结合使用时，可为局部疾病和转移范围提供更好的分期信息。
